Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma (Frontiers in Oncology, (2022), 12, (979519), 10.3389/fonc.2022.979519)

Abstract

In the published article, there was an error in Figure 1 as published. By mistake, we added the reference 18 for this figure. The corrected Figure 1 and its caption appear below. In the published article, an author name was incorrectly written as Sabbatini Roberto. The correct name is Roberto Sabbatini. The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.